Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-73,598
Closed -$11M 704
2025
Q3
$11M Sell
73,598
-92,548
-56% -$13.6M 0.06% 259
2025
Q2
$24.1M Sell
166,146
-22,997
-12% -$3.33M 0.14% 141
2025
Q1
$23.9M Buy
189,143
+128,947
+214% +$16.3M 0.15% 142
2024
Q4
$6.26M Sell
60,196
-13,338
-18% -$1.27M 0.04% 321
2024
Q3
$6.27M Buy
73,534
+39,862
+118% +$3.08M 0.04% 322
2024
Q2
$2.37M Sell
33,672
-5,107
-13% -$341K 0.01% 458
2024
Q1
$2.45M Sell
38,779
-5,660
-13% -$341K 0.02% 476
2023
Q4
$2.64M Sell
44,439
-6,800
-13% -$372K 0.02% 446
2023
Q3
$2.31M Sell
51,239
-2,903
-5% -$118K 0.02% 429
2023
Q2
$2.02M Hold
54,142
0.01% 494
2023
Q1
$1.96M Hold
54,142
0.01% 583
2022
Q4
$1.69M Hold
54,142
0.01% 609
2022
Q3
$2.28M Buy
54,142
+16,282
+43% +$656K 0.02% 562
2022
Q2
$1.54M Buy
+37,860
New +$1.4M 0.01% 554

Other funds holding LRN

Candriam SCA's LRN Position: Q4 2025 in Review

Candriam SCA sold out of Stride (LRN) in Q4 2025, closing a stake of 73,598 shares — an estimated $11M sold.

Candriam SCA first reported a position in LRN in Q2 2022 and held it in 14 quarters. The position peaked at $24.1M in Q2 2025. 397 funds tracked by Wall St. Rank hold LRN as of Q4 2025.

  • Candriam SCA reported no remaining Stride position as of Q4 2025 after selling out during the quarter.
  • Candriam SCA sold 73,598 Stride shares in Q4 2025, an estimated $11M.
  • Candriam SCA first reported a position in Stride in Q2 2022 and held it in 14 quarters.
  • Candriam SCA's Stride position peaked at $24.1M in Q2 2025.
  • 397 funds tracked by Wall St. Rank held Stride as of Q4 2025.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.